calcium dobesilate has been researched along with Albuminuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Mou, S; Ni, Z; Qi, C; Shao, X; Zhou, Y | 1 |
| Bian, LX; Gao, MJ; Li, B; Li, ML; Liu, M; Yu, GN | 1 |
1 trial(s) available for calcium dobesilate and Albuminuria
| Article | Year |
|---|---|
Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Topics: Aged; Albuminuria; Anti-Inflammatory Agents; Calcium Dobesilate; Chronic Disease; Creatine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney Function Tests; Male; Middle Aged; Prospective Studies | 2018 |
1 other study(ies) available for calcium dobesilate and Albuminuria
| Article | Year |
|---|---|
[Protective effect of calcium dobesilate against early diabetic nephropathy of rat kidney].
Topics: Albuminuria; Animals; Blood Glucose; Calcium Dobesilate; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelins; Glycated Hemoglobin; Hemostatics; Kidney Cortex; Male; Matrix Metalloproteinase 9; Plasminogen Activator Inhibitor 1; Random Allocation; Rats; Rats, Wistar | 2009 |